Dionysios Neofytos, MD

Dr. Neofytos has extensive experience and expertise in the diagnosis and management of infectious diseases, predominately those affecting immunocompromised patients such as bone marrow transplant recipients, solid organ transplant recipients, patients with leukemia, solid tumors, congenital immunodeficiencies, and other diseases treated with immunomodulating agents. During his career, Dr. Neofytos has designed, executed and participated in multiple phase II-IV clinical trials and observational investigator initiated research projects. In addition to direct clinical care and clinical research experience, he has studied and published on the epidemiology of viral and fungal infectious diseases in susceptible patient populations. His analytical skills have been supported by taking multiple biostatistics courses and completing a Master in Public Health.

Dr. Neofytos has successfully trained and mentored a large number of medical students, residents, and fellows and supervised multiple teams of clinical research coordinators, database managers, registered nurses, physician assistants and nurse practitioners. Dr. Neofytos has been invited to present his work in national and international meetings, published more than 20 original papers, and has served as a consultant and advisory board member for a number of pharmaceutical companies. 

Clinical Expertise

Infectious Diseases in immunocompromised hosts, including bone marrow and solid organ transplant recipients, patients with solid tumors and leukemia

Languages Spoken
English; French; Greek

MD, University of Athens School of Medicine (Greece); MPH, Thomas Jefferson University (Pennsylvania)


Newton-Wellesly Hospital (Massachusetts)


Thomas Jefferson University Hospital (Pennsylvania)

Board Certifications

Infectious Disease; Internal Medicine

Publications by Dionysios Neofytos
Visit PubMed for full listing of Dionysios Neofytos journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.